BILI three-lens brief
Evidence-based stock research on BILI. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.04% yesterday. · Trading at 6% of its 52-week range — deep in the lower band.
- Moved -2.04% yesterday.
- Trading at 6% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Analyst mean target $25.33 — 82% above current (31 analysts).
- Earnings scheduled 2026-11-24.
BILI closed at $13.95 (-2.04%) as of 2026-11-12. Market cap: $5.58B. P/E (trailing) 27.9. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $25.33 — 82% above current (31 analysts).. Concerns: moved -2.04% yesterday.; trading at 6% of its 52-week range — deep in the lower band.. Last quarter: Revenue $7.94B, net income $343.73M. Watching for: 2026-11-24 earnings release (12 days out).
Why three lenses on BILI, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BILI across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/BILI" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BILI brief"></iframe>